Home > 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone > 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone(147-94-4)
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone(147-94-4)
Supplier Product Identification
Physical and Chemical Properties
First Aid Measures
Handling and Storage
Hazards Identification
Exposure Controls/Personal Protection
Fire Fighting Measures
Accidental Release Measures
Stability and Reactivity
Product Identification
Product Name
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone
Synonyms
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine
AC-1075
Alexan
Arabinocitidine
Ara-C
Cytarabin
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine
AC-1075
Alexan
Arabinocitidine
Ara-C
Cytarabin
CAS
147-94-4
147-94-4
Formula
C9H13N3O5
C9H13N3O5
Molecular Weight
243.22
243.22
EINECS
205-705-9
205-705-9
RTECS
HA5425000
HA5425000
RTECS Class
Tumorigen; Drug; Mutagen; Reproductive Effector; Human Data; Primary Irritant
Tumorigen; Drug; Mutagen; Reproductive Effector; Human Data; Primary Irritant
Merck
12,2853
12,2853
Beilstein/Gmelin
89175
89175
Beilstein Reference
4-25-00-03669
4-25-00-03669
Physical and Chemical Properties
Appearance
White to off white, lyophilized powder. Odorless.
White to off white, lyophilized powder. Odorless.
Solubility in water
Soluble.
Soluble.
Melting Point
223 - 224
223 - 224
Partition Coefficient
-2.18
-2.18
Usage
Antileukemic agent.
Antileukemic agent.
First Aid Measures
Ingestion
DO NOT INDUCE VOMITING. If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Be prepared to transport the victim to a hospital if advised by a physician.
DO NOT INDUCE VOMITING. If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Be prepared to transport the victim to a hospital if advised by a physician.
Inhalation
IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used.
IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used.
Skin
IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.
IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.
Eyes
First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.
First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.
Handling and Storage
Storage
Store in a tightly closed container in a cool area.
Store in a tightly closed container in a cool area.
Handling
Avoid all fors of unprotected contact when mixing and administering this product.
Avoid all fors of unprotected contact when mixing and administering this product.
Hazards Identification
Inhalation
Adult respiratory distress syndrome has been reported. Causes irritation. Poisonous.
Adult respiratory distress syndrome has been reported. Causes irritation. Poisonous.
Skin
Rash is a common adverse effect of cytarabine therapy. Poisonous on contact.
Rash is a common adverse effect of cytarabine therapy. Poisonous on contact.
Eyes
Irritation.
Irritation.
Ingestion
Poisonous.
Poisonous.
Exposure Controls/Personal Protection
Personal Protection
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Respirators
Wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter.
Wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter.
Exposure Effects
with therapeutic use - CNS toxicity is associated with high dose cytarabine therapy, and includes cerebral and cerebellar dysfunction. Peripheral neuropathy may develop. Teratogenicity has been reported in animal studies.
with therapeutic use - CNS toxicity is associated with high dose cytarabine therapy, and includes cerebral and cerebellar dysfunction. Peripheral neuropathy may develop. Teratogenicity has been reported in animal studies.
Fire Fighting Measures
Fire Fighting
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Accidental Release Measures
Small spills/leaks
STORAGE PRECAUTIONS: You should protect this material from exposure to light, and store it in a refrigerator.
STORAGE PRECAUTIONS: You should protect this material from exposure to light, and store it in a refrigerator.
Stability and Reactivity
Stability
Stable.
Stable.
Incompatibilities
Strong oxidizing agents.
Strong oxidizing agents.
Decomposition
Emits toxic fumes when heated.
Emits toxic fumes when heated.
Contact
More
- Company Name:Shanghai Norky Pharmaceutical Co., Ltd.
- Tel:021-021-61075308 15216782696
- Fax:021-61075308
- WebSite:https://www.norkypharm.com
- Company Name:Jiangsu Xinderui Pharmaceutical Technology Co., Ltd
- Tel:0518-80639699 19852363252
- Fax:
- WebSite:http://www.xdrpharm.com
- Company Name:Zhenjiang Hongyu Biotechnology Co., Ltd
- Tel: 15189105787
- Fax:
- WebSite:http://www.zjhysw.cn/
- Company Name:Panjin Jiahe Shengshi Pharmaceutical Technology Co., Ltd
- Tel:18504053675 13032431717
- Fax:
- WebSite:http://www.jhssw.com/
- Company Name:Nanjing Yunzhi Xinhe Biotechnology Co., Ltd
- Tel:19852363252; 19852363252
- Fax:
- WebSite:https://www.yunzhipharm.com/